{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:22:15Z","timestamp":1791404535241,"version":"4.3.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alzheimer\u2019s disease (AD) is the most common neurodegenerative disorder in the elderly, resulting in gradual destruction of cognitive abilities. Research on the development of various AD treatments is underway; however, no definitive treatment has been developed yet. Herein, we present induced pluripotent stem cell (iPSC)-derived cortical neural stem cell secretome (CNSC-SE) as a new treatment candidate for AD and explore its efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We first assessed the effects of CNSC-SE treatment on neural maturation and electromagnetic signal during cortical nerve cell differentiation. Then to confirm the efficacy in vivo, CNSC-SE was administered to the 5\u00d7FAD mouse model through the nasal cavity (5\u00a0\u03bcg\/g, once a week, 4\u00a0weeks). The cell-mediated effects on nerve recovery, amyloid beta (A\u03b2) plaque aggregation, microglial and astrocyte detection in the brain, and neuroinflammatory responses were investigated. Metabolomics analysis of iPSC-derived CNSC-SE revealed that it contained components that could exert neuro-protective effects or amplify cognitive restorative effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Human iPSC-derived CNSC-SE increased neuronal proliferation and dendritic structure formation in vitro. Furthermore, CNSC-SE-treated iPSC-derived cortical neurons acquired electrical network activity and action potential bursts. The 5\u00d7FAD mice treated with CNSC-SE showed memory restoration and reduced A\u03b2 plaque accumulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that the iPSC-derived CNSC-SE may serve as a potential, non-invasive therapeutic option for AD in reducing amyloid infiltration and restoring memory.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40035-023-00384-8","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T05:01:39Z","timestamp":1699506099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Hyunkyung","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Yejean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Woon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeju","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hwa","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeri Alice","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyeon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"5800","key":"384_CR1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG. A century of Alzheimer\u2019s disease. Science. 2006;314(5800):777\u201381.","journal-title":"Science"},{"issue":"1","key":"384_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"384_CR3","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar M, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8(1):e12295.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"5054","key":"384_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"7","key":"384_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019;15(7):888\u201398.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"384_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"384_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(1):32.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"384_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.phrs.2018.01.017","volume":"130","author":"C Balducci","year":"2018","unstructured":"Balducci C, Forloni G. Novel targets in Alzheimer\u2019s disease: a special focus on microglia. Pharmacol Res. 2018;130:402\u201313.","journal-title":"Pharmacol Res"},{"key":"384_CR10","doi-asserted-by":"crossref","unstructured":"Tampi RR, Forester BP, Agronin M. Aducanumab: evidence from clinical trial data and controversies. Drugs Context. 2021;10.","DOI":"10.7573\/dic.2021-7-3"},{"issue":"1","key":"384_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","volume":"12","author":"M Tolar","year":"2020","unstructured":"Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M. Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval. Alzheimers Res Ther. 2020;12(1):95.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"384_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-021-00838-z","volume":"13","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S. Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimers Res Ther. 2021;13(1):98.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"384_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","volume":"6","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Grundke-Iqbal I. Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies. Alzheimers Dement. 2010;6(5):420\u20134.","journal-title":"Alzheimers Dement"},{"issue":"15","key":"384_CR14","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2174\/15680266113139990135","volume":"13","author":"MC Carreiras","year":"2013","unstructured":"Carreiras MC, Mendes E, Perry MJ, Francisco AP, Marco-Contelles J. The multifactorial nature of Alzheimer\u2019s disease for developing potential therapeutics. Curr Top Med Chem. 2013;13(15):1745\u201370.","journal-title":"Curr Top Med Chem"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-981-15-4370-8_4","volume":"1266","author":"F Han","year":"2020","unstructured":"Han F, Bi J, Qiao L, Arancio O. Stem cell therapy for Alzheimer\u2019s disease. Adv Exp Med Biol. 2020;1266:39\u201355.","journal-title":"Adv Exp Med Biol"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11010120","volume":"11","author":"Y Duan","year":"2023","unstructured":"Duan Y, Lyu L, Zhan S. Stem cell therapy for Alzheimer\u2019s disease: a scoping review for 2017\u20132022. Biomedicines. 2023;11:1.","journal-title":"Biomedicines."},{"issue":"32","key":"384_CR17","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A. 2009;106(32):13594\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"384_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fnagi.2016.00282","volume":"8","author":"X Li","year":"2016","unstructured":"Li X, Zhu H, Sun X, Zuo F, Lei J, Wang Z, et al. Human neural stem cell transplantation rescues cognitive defects in APP\/PS1 model of Alzheimer\u2019s disease by enhancing neuronal connectivity and metabolic activity. Front Aging Neurosci. 2016;8:282.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"384_CR19","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","volume":"8","author":"LM McGinley","year":"2018","unstructured":"McGinley LM, Kashlan ON, Bruno ES, Chen KS, Hayes JM, Kashlan SR, et al. Human neural stem cell transplantation improves cognition in a murine model of Alzheimer\u2019s disease. Sci Rep. 2018;8(1):14776.","journal-title":"Sci Rep"},{"issue":"1","key":"384_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","volume":"8","author":"T Duncan","year":"2017","unstructured":"Duncan T, Valenzuela M. Alzheimer\u2019s disease, dementia, and stem cell therapy. Stem Cell Res Ther. 2017;8(1):111.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"384_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s12015-018-9817-x","volume":"14","author":"Z Abbasi-Malati","year":"2018","unstructured":"Abbasi-Malati Z, Roushandeh AM, Kuwahara Y, Roudkenar MH. Mesenchymal stem cells on horizon: a new arsenal of therapeutic agents. Stem Cell Rev Rep. 2018;14(4):484\u201399.","journal-title":"Stem Cell Rev Rep"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnagi.2014.00030","volume":"6","author":"KO Garcia","year":"2014","unstructured":"Garcia KO, Ornellas FL, Martin PK, Patti CL, Mello LE, Frussa-Filho R, et al. Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:30.","journal-title":"Front Aging Neurosci"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fncel.2018.00317","volume":"12","author":"EE Reza-Zaldivar","year":"2018","unstructured":"Reza-Zaldivar EE, Hernandez-Sapiens MA, Minjarez B, Gutierrez-Mercado YK, Marquez-Aguirre AL, Canales-Aguirre AA. Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer\u2019s disease. Front Cell Neurosci. 2018;12:317.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"384_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41(9):653\u201364.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"384_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beha.2011.01.004","volume":"24","author":"A Uccelli","year":"2011","unstructured":"Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol. 2011;24(1):59\u201364.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"384_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/med.21309","volume":"34","author":"X Fan","year":"2014","unstructured":"Fan X, Sun D, Tang X, Cai Y, Yin ZQ, Xu H. Stem-cell challenges in the treatment of Alzheimer\u2019s disease: a long way from bench to bedside. Med Res Rev. 2014;34(5):957\u201378.","journal-title":"Med Res Rev"},{"issue":"1","key":"384_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F, et al. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28(1):203\u201318.","journal-title":"Cell Death Differ"},{"key":"384_CR28","doi-asserted-by":"publisher","first-page":"1011225","DOI":"10.3389\/fnmol.2022.1011225","volume":"15","author":"S Regmi","year":"2022","unstructured":"Regmi S, Liu DD, Shen M, Kevadiya BD, Ganguly A, Primavera R, et al. Mesenchymal stromal cells for the treatment of Alzheimer\u2019s disease: strategies and limitations. Front Mol Neurosci. 2022;15:1011225.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"384_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-200219","volume":"77","author":"J Kim","year":"2020","unstructured":"Kim J, Lee Y, Lee S, Kim K, Song M, Lee J. Mesenchymal stem cell therapy and alzheimer\u2019s disease: current status and future perspectives. J Alzheimers Dis. 2020;77(1):1\u201314.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"384_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-150040","volume":"47","author":"SB Rangasamy","year":"2015","unstructured":"Rangasamy SB, Corbett GT, Roy A, Modi KK, Bennett DA, Mufson EJ, et al. Intranasal delivery of NEMO-binding domain peptide prevents memory loss in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47(2):385\u2013402.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"384_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5966\/sctm.2015-0103","volume":"5","author":"LM McGinley","year":"2016","unstructured":"McGinley LM, Sims E, Lunn JS, Kashlan ON, Chen KS, Bruno ES, et al. Human cortical neural stem cells expressing insulin-like growth factor-I: a novel cellular therapy for Alzheimer\u2019s disease. Stem Cells Transl Med. 2016;5(3):379\u201391.","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"384_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/stem.3456","volume":"39","author":"S Herman","year":"2021","unstructured":"Herman S, Fishel I, Offen D. Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases. Stem Cells. 2021;39(12):1589\u2013600.","journal-title":"Stem Cells"},{"issue":"1","key":"384_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40263-020-00781-x","volume":"35","author":"M Hallschmid","year":"2021","unstructured":"Hallschmid M. Intranasal insulin for Alzheimer\u2019s disease. CNS Drugs. 2021;35(1):21\u201337.","journal-title":"CNS Drugs"},{"issue":"40","key":"384_CR34","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"1","key":"384_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/h0077579","volume":"93","author":"CA Barnes","year":"1979","unstructured":"Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol. 1979;93(1):74\u2013104.","journal-title":"J Comp Physiol Psychol"},{"issue":"3","key":"384_CR36","doi-asserted-by":"publisher","first-page":"e1531","DOI":"10.1002\/term.2578","volume":"12","author":"YA Rim","year":"2018","unstructured":"Rim YA, Park N, Nam Y, Ham DS, Kim JW, Ha HY, et al. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea. J Tissue Eng Regen Med. 2018;12(3):e1531\u20136.","journal-title":"J Tissue Eng Regen Med"},{"issue":"10","key":"384_CR37","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/nprot.2012.116","volume":"7","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Livesey FJ. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc. 2012;7(10):1836\u201346.","journal-title":"Nat Protoc"},{"issue":"6286","key":"384_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136.","journal-title":"Science"},{"issue":"3","key":"384_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jphs.2020.12.007","volume":"145","author":"SY Lee","year":"2021","unstructured":"Lee SY, Chung WS. The roles of astrocytic phagocytosis in maintaining homeostasis of brains. J Pharmacol Sci. 2021;145(3):223\u20137.","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"384_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jnr.24419","volume":"98","author":"E Gabande-Rodriguez","year":"2020","unstructured":"Gabande-Rodriguez E, Keane L, Capasso M. Microglial phagocytosis in aging and Alzheimer\u2019s disease. J Neurosci Res. 2020;98(2):284\u201398.","journal-title":"J Neurosci Res"},{"issue":"7331","key":"384_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature09667","volume":"469","author":"DY Chen","year":"2011","unstructured":"Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, et al. A critical role for IGF-II in memory consolidation and enhancement. Nature. 2011;469(7331):491\u20137.","journal-title":"Nature"},{"key":"384_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neulet.2013.05.038","volume":"548","author":"EY Jeong","year":"2013","unstructured":"Jeong EY, Kim S, Jung S, Kim G, Son H, Lee DH, et al. Enhancement of IGF-2-induced neurite outgrowth by IGF-binding protein-2 and osteoglycin in SH-SY5Y human neuroblastoma cells. Neurosci Lett. 2013;548:249\u201354.","journal-title":"Neurosci Lett"},{"key":"384_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fendo.2019.00822","volume":"10","author":"S Khan","year":"2019","unstructured":"Khan S. IGFBP-2 signaling in the brain: from brain development to higher order brain functions. Front Endocrinol. 2019;10:822.","journal-title":"Front Endocrinol"},{"issue":"2","key":"384_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1615\/CritRevOncog.v17.i2.30","volume":"17","author":"DN Boone","year":"2012","unstructured":"Boone DN, Lee AV. Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling. Crit Rev Oncog. 2012;17(2):161\u201373.","journal-title":"Crit Rev Oncog"},{"issue":"33","key":"384_CR45","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.0343-15.2015","volume":"35","author":"G Gontier","year":"2015","unstructured":"Gontier G, George C, Chaker Z, Holzenberger M, Aid S. Blocking IGF signaling in adult neurons alleviates Alzheimer\u2019s disease pathology through amyloid-beta clearance. J Neurosci. 2015;35(33):11500\u201313.","journal-title":"J Neurosci"},{"key":"384_CR46","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.6061\/clinics\/2019\/e894","volume":"74","author":"RT Souza","year":"2019","unstructured":"Souza RT, Mayrink J, Leite DF, Costa ML, Calderon IM, Rocha Filho EA, et al. Metabolomics applied to maternal and perinatal health: a review of new frontiers with a translation potential. Clinics. 2019;74:e894.","journal-title":"Clinics"},{"issue":"10","key":"384_CR47","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1177\/0269881119856558","volume":"33","author":"JC Pei","year":"2019","unstructured":"Pei JC, Hung WL, Lin BX, Shih MH, Lu LY, Luo DZ, et al. Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia. J Psychopharmacol. 2019;33(10):1288\u2013302.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"384_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-130998","volume":"38","author":"N van Wijk","year":"2014","unstructured":"van Wijk N, Broersen LM, de Wilde MC, Hageman RJ, Groenendijk M, Sijben JW, et al. Targeting synaptic dysfunction in Alzheimer\u2019s disease by administering a specific nutrient combination. J Alzheimers Dis. 2014;38(3):459\u201379.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"384_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1254\/jphs.08R01CR","volume":"108","author":"K Aoyama","year":"2008","unstructured":"Aoyama K, Watabe M, Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci. 2008;108(3):227\u201338.","journal-title":"J Pharmacol Sci"},{"key":"384_CR50","doi-asserted-by":"publisher","first-page":"659402","DOI":"10.3389\/fnagi.2021.659402","volume":"13","author":"BD Paul","year":"2021","unstructured":"Paul BD. Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer\u2019s Disease. Front Aging Neurosci. 2021;13:659402.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"384_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1471-4159.2010.06935.x","volume":"115","author":"E Beard","year":"2010","unstructured":"Beard E, Braissant O. Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem. 2010;115(2):297\u2013313.","journal-title":"J Neurochem"},{"issue":"5","key":"384_CR52","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1046\/j.1471-4159.2000.0741968.x","volume":"74","author":"GJ Brewer","year":"2000","unstructured":"Brewer GJ, Wallimann TW. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem. 2000;74(5):1968\u201378.","journal-title":"J Neurochem"},{"issue":"1529","key":"384_CR53","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1098\/rspb.2003.2492","volume":"270","author":"C Rae","year":"2003","unstructured":"Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc Biol Sci. 2003;270(1529):2147\u201350.","journal-title":"Proc Biol Sci"},{"issue":"2","key":"384_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1079\/NRR200367","volume":"16","author":"RF Butterworth","year":"2003","unstructured":"Butterworth RF. Thiamin deficiency and brain disorders. Nutr Res Rev. 2003;16(2):277\u201384.","journal-title":"Nutr Res Rev"},{"issue":"4","key":"384_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00997071","volume":"5","author":"RF Butterworth","year":"1990","unstructured":"Butterworth RF, Besnard AM. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer\u2019s disease. Metab Brain Dis. 1990;5(4):179\u201384.","journal-title":"Metab Brain Dis"},{"issue":"3","key":"384_CR56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1254\/jjp.68.349","volume":"68","author":"MY Geng","year":"1995","unstructured":"Geng MY, Saito H, Katsuki H. The effects of thiamine and oxythiamine on the survival of cultured brain neurons. Jpn J Pharmacol. 1995;68(3):349\u201352.","journal-title":"Jpn J Pharmacol"},{"issue":"4","key":"384_CR57","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2337\/db10-1160","volume":"60","author":"AS Ibrahim","year":"2011","unstructured":"Ibrahim AS, El-Remessy AB, Matragoon S, Zhang W, Patel Y, Khan S, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes. 2011;60(4):1122\u201333.","journal-title":"Diabetes"},{"issue":"6","key":"384_CR58","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1167\/iovs.14-14051","volume":"55","author":"V Maneu","year":"2014","unstructured":"Maneu V, Noailles A, Megias J, Gomez-Vicente V, Carpena N, Gil ML, et al. Retinal microglia are activated by systemic fungal infection. Invest Ophthalmol Vis Sci. 2014;55(6):3578\u201385.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"384_CR59","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.7150\/thno.26164","volume":"8","author":"M Zhang","year":"2018","unstructured":"Zhang M, Qian C, Zheng ZG, Qian F, Wang Y, Thu PM, et al. Jujuboside A promotes Abeta clearance and ameliorates cognitive deficiency in Alzheimer\u2019s disease through activating Axl\/HSP90\/PPARgamma pathway. Theranostics. 2018;8(15):4262\u201378.","journal-title":"Theranostics"},{"issue":"1","key":"384_CR60","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-016-0751-z","volume":"13","author":"T Park","year":"2016","unstructured":"Park T, Chen H, Kevala K, Lee JW, Kim HY. N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP\/PKA-dependent signaling. J Neuroinflammation. 2016;13(1):284.","journal-title":"J Neuroinflammation"},{"key":"384_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/nu11030648","volume":"11","author":"T Muhammad","year":"2019","unstructured":"Muhammad T, Ikram M, Ullah R, Rehman SU, Kim MO. Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4\/NF-kappaB signaling. Nutrients. 2019;11:3.","journal-title":"Nutrients"},{"issue":"2","key":"384_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Trepanier MO, Giuliano V, Bazinet RP. Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry. 2018;23(2):177\u201398.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"384_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-015-0139-9","volume":"7","author":"DG Walker","year":"2015","unstructured":"Walker DG, Lue LF. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther. 2015;7(1):56.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"384_CR64","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1006\/bbrc.1996.1112","volume":"224","author":"Y Imai","year":"1996","unstructured":"Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun. 1996;224(3):855\u201362.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"384_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57(1):1.","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"384_CR66","doi-asserted-by":"publisher","first-page":"200","DOI":"10.18240\/ijo.2021.02.04","volume":"14","author":"FJ Shi","year":"2021","unstructured":"Shi FJ, Xie H, Zhang CY, Qin HF, Zeng XW, Lou H, et al. Is Iba-1 protein expression a sensitive marker for microglia activation in experimental diabetic retinopathy? Int J Ophthalmol. 2021;14(2):200\u20138.","journal-title":"Int J Ophthalmol"},{"key":"384_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuroscience.2014.05.010","volume":"274","author":"A Basta-Kaim","year":"2014","unstructured":"Basta-Kaim A, Szczesny E, Glombik K, Slusarczyk J, Trojan E, Tomaszewski KA, et al. Prenatal stress leads to changes in IGF-1 binding proteins network in the hippocampus and frontal cortex of adult male rat. Neuroscience. 2014;274:59\u201368.","journal-title":"Neuroscience"},{"issue":"27","key":"384_CR68","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1523\/JNEUROSCI.1002-13.2013","volume":"33","author":"KC Roet","year":"2013","unstructured":"Roet KC, Franssen EH, de Bree FM, Essing AH, Zijlstra SJ, Fagoe ND, et al. A multilevel screening strategy defines a molecular fingerprint of proregenerative olfactory ensheathing cells and identifies SCARB2, a protein that improves regenerative sprouting of injured sensory spinal axons. J Neurosci. 2013;33(27):11116\u201335.","journal-title":"J Neurosci"},{"issue":"3","key":"384_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1677\/joe.0.1820445","volume":"182","author":"CM Reijnders","year":"2004","unstructured":"Reijnders CM, Koster JG, van Buul-Offers SC. Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata. J Endocrinol. 2004;182(3):445\u201355.","journal-title":"J Endocrinol"},{"issue":"1","key":"384_CR70","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0306-4522(94)90069-8","volume":"61","author":"E Castren","year":"1994","unstructured":"Castren E, Ohga Y, Berzaghi MP, Tzimagiorgis G, Thoenen H, Lindholm D. bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain. Neuroscience. 1994;61(1):165\u201377.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"384_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0169-328X(92)90151-Z","volume":"15","author":"ND Klempt","year":"1992","unstructured":"Klempt ND, Klempt M, Gunn AJ, Singh K, Gluckman PD. Expression of insulin-like growth factor-binding protein 2 (IGF-BP 2) following transient hypoxia-ischemia in the infant rat brain. Brain Res Mol Brain Res. 1992;15(1\u20132):55\u201361.","journal-title":"Brain Res Mol Brain Res"},{"key":"384_CR72","doi-asserted-by":"publisher","first-page":"37889","DOI":"10.1038\/srep37889","volume":"6","author":"S Oka","year":"2016","unstructured":"Oka S, Leon J, Sakumi K, Ide T, Kang D, LaFerla FM, et al. Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer\u2019s disease. Sci Rep. 2016;6:37889.","journal-title":"Sci Rep"},{"key":"384_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","volume":"101\u2013102","author":"S Lista","year":"2013","unstructured":"Lista S, Faltraco F, Prvulovic D, Hampel H. Blood and plasma-based proteomic biomarker research in Alzheimer\u2019s disease. Prog Neurobiol. 2013;101\u2013102:1\u201317.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"384_CR74","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s11682-016-9636-0","volume":"11","author":"EM Lane","year":"2017","unstructured":"Lane EM, Hohman TJ, Jefferson AL. Alzheimer\u2019s disease neuroimaging I. Insulin-like growth factor binding protein-2 interactions with Alzheimer\u2019s disease biomarkers. Brain Imaging Behav. 2017;11(6):1779\u201386.","journal-title":"Brain Imaging Behav"},{"issue":"9","key":"384_CR75","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/acn3.50854","volume":"6","author":"ER McGrath","year":"2019","unstructured":"McGrath ER, Himali JJ, Levy D, Conner SC, DeCarli CS, Pase MP, et al. Circulating IGFBP-2: a novel biomarker for incident dementia. Ann Clin Transl Neurol. 2019;6(9):1659.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"384_CR76","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrendo.2014.208","volume":"11","author":"AN Ziegler","year":"2015","unstructured":"Ziegler AN, Levison SW, Wood TL. Insulin and IGF receptor signalling in neural-stem-cell homeostasis. Nat Rev Endocrinol. 2015;11(3):161\u201370.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"384_CR77","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1038\/s41388-020-1154-2","volume":"39","author":"T Li","year":"2020","unstructured":"Li T, Forbes ME, Fuller GN, Li J, Yang X, Zhang W. IGFBP2: integrative hub of developmental and oncogenic signaling network. Oncogene. 2020;39(11):2243\u201357.","journal-title":"Oncogene"},{"issue":"15","key":"384_CR78","doi-asserted-by":"publisher","first-page":"e2026804118","DOI":"10.1073\/pnas.2026804118","volume":"118","author":"CA Simintiras","year":"2021","unstructured":"Simintiras CA, Dhakal P, Ranjit C, Fitzgerald HC, Balboula AZ, Spencer TE. Capture and metabolomic analysis of the human endometrial epithelial organoid secretome. Proc Natl Acad Sci U S A. 2021;118(15):e2026804118.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00384-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00384-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T08:29:10Z","timestamp":1699518550000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00384-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00384-8","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the Laboratory Animals Welfare Act, the Guide for the Care and Use of Laboratory Animals, and the Guidelines and Policies for Rodent Experiments provided by the Institutional Animal Care and Use Committee (IACUC) of the School of Medicine, The Catholic University of Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}